FORTE BIOSCIENCES INC's ticker is FBRX and the CUSIP is 34962G109. A total of 51 filers reported holding FORTE BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $440,117 | -36.3% | 664,830 | 0.0% | 0.00% | – |
| Q2 2023 | $691,423 | +5.7% | 664,830 | +2.7% | 0.00% | – |
| Q1 2023 | $654,023 | +1.0% | 647,548 | 0.0% | 0.00% | – |
| Q4 2022 | $647,548 | -6.4% | 647,548 | +0.0% | 0.00% | – |
| Q3 2022 | $692,000 | +15.5% | 647,293 | +40.4% | 0.00% | – |
| Q2 2022 | $599,000 | +87.2% | 461,134 | +110.5% | 0.00% | – |
| Q1 2022 | $320,000 | -71.4% | 219,083 | -58.0% | 0.00% | – |
| Q4 2021 | $1,117,000 | -32.5% | 522,130 | -6.6% | 0.00% | – |
| Q3 2021 | $1,654,000 | -90.7% | 558,837 | +6.1% | 0.00% | – |
| Q2 2021 | $17,701,000 | +15.0% | 526,518 | +17.2% | 0.00% | – |
| Q1 2021 | $15,397,000 | -4.7% | 449,293 | +1.2% | 0.00% | – |
| Q4 2020 | $16,160,000 | +101.8% | 443,844 | +168.9% | 0.00% | – |
| Q3 2020 | $8,008,000 | +803.8% | 165,072 | +171.8% | 0.00% | – |
| Q2 2020 | $886,000 | – | 60,744 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 84,989 | $3,094,000 | 1.41% |
| BVF INC/IL | 718,788 | $26,171,000 | 1.03% |
| ArrowMark Colorado Holdings LLC | 2,936,708 | $106,926,000 | 0.83% |
| MYDA Advisors LLC | 28,000 | $1,019,000 | 0.30% |
| Maven Securities LTD | 83,374 | $3,036,000 | 0.30% |
| Parkman Healthcare Partners LLC | 31,098 | $1,132,000 | 0.29% |
| Woodline Partners LP | 192,266 | $7,000,000 | 0.19% |
| Sepio Capital, LP | 58,591 | $2,133,000 | 0.18% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 325,000 | $11,833,000 | 0.17% |
| Perceptive Advisors | 350,000 | $12,744,000 | 0.14% |